Novel SARS-CoV-2 diagnostic assay reagents were developed by UCAM as part of the AfriDx project. Below you can find 

Development of Boon-Enzymes

This module will cover the general protocols utilised for the development of novel BoonEnzymes. Protocols for polymerase chain reaction, gel extraction, klenow assembly, and preliminary expression will be provided, in addition to tips for E. coli transformations.

The Boon-Enzymes are heterogenous recombinant proteins that has been specifically designed to immobilise onto silica (component: R5 silaffin-tag), provide visual indication of protein expression and allow for protein tracking (component: mCherry), and either amplify targeted DNA/RNA (component: Bst DNA polymerase, reverse transcriptase X) or specifically bind to antigen targets (component: single-chain variable fragment (scFv)). The silaffin-tag will immobilise onto silica by simply incubating the two together in phosphatebuffered saline (PBS) under basic conditions and room temperature. The mCherry gives the protein a pink colour that can be seen without any specialty equipment but can be tracked in spectrophotometers with an excitation of 587 nm and an emission of 607 nm. Finally, the enzymes/scFv are active under standard LAMP/PCR or lateral flow test/ELISA conditions and
can be utilised without further adjustments. Those wanting to develop novel Boon-Enzymes can retain the existing affinity-tag fluorescent protein core and swap out the enzyme for further applications.

Download the Development of Boon-Enzymes Handbook >>

Manufacturing Engineered Boon2-BST

This module will cover both the expression and purification protocol for the Engineered Boon2-BST. Boon2-BST is a heterogenous recombinant protein that has been specifically designed to immobilise onto silica (component: Δ3R5 silaffin-tag), provide visual indication of protein expression and allow for protein tracking (component: mCherry), and amplify targeted DNA using loop-mediated isothermal amplification by Bst DNA Polymerase.

Two methods are presented for protein expression (autoinduction and standard IPTG) to allow the user to utilise the protocol that best fits into their environment. The purification protocol aims to allow the user to purify the protein using silica immobilisation.